Literature DB >> 3161326

The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature.

W P Follansbee, E I Curtiss, P S Rahko, T A Medsger, S J Lavine, G R Owens, V D Steen.   

Abstract

The electrocardiographic findings in 102 consecutive patients with scleroderma were reviewed to determine the frequency and nature of the electrocardiographic abnormalities associated with this disease. Septal infarction pattern unassociated with QRS prolongation was present in 10 percent, compared with none of 96 control subjects (p less than 0.001). Ventricular conduction abnormalities were present in 17 percent. A normal electrocardiogram was obtained in 49 percent. A subset of 48 patients underwent detailed cardiopulmonary evaluation including exercise thallium scintigraphy, rest and exercise radionuclide ventriculography, pulmonary function tests, and chest roentgenography. Functional correlations of the electrocardiographic findings were examined in this subset. Septal infarction pattern (five of 48) and ventricular conduction abnormalities (10 of 48) were both associated with septal or anteroseptal thallium perfusion abnormalities (10 of 15 versus six of 33 of the remainder, p less than 0.005), which were present despite normal coronary angiographic results. Thallium defect scores were greater in patients with septal infarction pattern or ventricular conduction abnormalities compared with the remainder (defect scores 3.0 +/- 2.6 versus 1.4 +/- 2.2, respectively, p less than 0.025). In patients with ventricular conduction abnormalities, both left bundle branch block and right bundle branch block with left anterior fascicular block were associated with abnormal left ventricular function, whereas isolated right bundle branch block or left anterior fascicular block was associated with normal left ventricular function. A normal electrocardiographic finding (19 of 48) was associated with normal left ventricular function at rest (19 of 19). However, 11 of 19 (58 percent) had thallium perfusion defects and four of 19 (21 percent) had an abnormal response to exercise, although in none was the peak ejection fraction less than 50 percent. It is concluded that both septal infarction pattern and ventricular conduction abnormalities are electrocardiographic abnormalities associated with scleroderma heart disease; they appear to be a result of myocardial fibrosis. Some degree of myocardial fibrosis may be present with a normal electrocardiographic result, but significant left ventricular dysfunction is unlikely. Septal infarction pattern and ventricular conduction abnormalities, when present, are indicators of more advanced fibrosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161326     DOI: 10.1016/0002-9343(85)90008-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease.

Authors:  Anna Biełous-Wilk; Małgorzata Poreba; Edyta Staniszewska-Marszałek; Rafał Poreba; Maciej Podgórski; Dariusz Kałka; Dariusz Jagielski; Lesław Rusiecki; Witold Pilecki; Eugeniusz Baran; Ryszard Andrzejak; Małgorzata Sobieszczańska
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

Review 2.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 3.  Cardiac manifestations in systemic sclerosis.

Authors:  Sevdalina Lambova
Journal:  World J Cardiol       Date:  2014-09-26

4.  Cardiovascular Complications of Collagen Vascular Disease.

Authors:  Gary E. Sander; Thomas D. Giles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

5.  Complete heart block in a patient with systemic sclerosis.

Authors:  I Moyssakis; D P Papadopoulos; A G Tzioufas; V Votteas
Journal:  Clin Rheumatol       Date:  2005-11-01       Impact factor: 2.980

Review 6.  The heart in systemic sclerosis.

Authors:  Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

7.  Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma.

Authors:  A Kahan; J Y Devaux; B Amor; C J Menkes; S Weber; J M Foult; A Venot; F Guerin; M Degeorges; J C Roucayrol
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

Review 8.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

9.  QT variability index in patients with systemic sclerosis.

Authors:  Udi Nussinovitch; Shiri Rubin; Yair Levy; Merav Lidar; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2018-10-01

Review 10.  Cardiac arrhythmias and conduction defects in systemic sclerosis.

Authors:  Alessandra Vacca; Christophe Meune; Jessica Gordon; Lorinda Chung; Susanna Proudman; Shervin Assassi; Mandana Nikpour; Tatiana S Rodriguez-Reyna; Dinesh Khanna; Robert Lafyatis; Marco Matucci-Cerinic; Oliver Distler; Yannick Allanore
Journal:  Rheumatology (Oxford)       Date:  2013-11-15       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.